SAMANTHA JACKSON: Open Payments
NPI 1922855295 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 39 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $633 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $141 |
| Novo Nordisk Inc | 6 | $114 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| Lilly USA, LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Exact Sciences Corporation | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $31 |
Products named: VRAYLAR, Ozempic, MOUNJARO, CAPLYTA, The Cologuard Plus Collection Kit, KEVEYIS, REXULTI, HETLIOZ.
Industry payments across FL — which companies pay providers there.
